Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00133068 · ClinicalTrials.gov registry record · Phase 4
Collaboration to Reduce Disparities in Hypertension
A Phase 4 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 4
- Development phase
- 802
- Enrollment target
NCT00133068: Completed Phase 4 study, sponsored by University of Pennsylvania.
NCT00133068 is a Phase 4 study that has completed, run by University of Pennsylvania. The registered enrollment target is 802 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (55% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00133068, a Phase 4 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 802 participants
- Enrollment target
Study Summary
A large number of African-American and low socioeconomic patients have poorly controlled high blood pressure because of not being able to take their high blood pressure medications. This puts these patients at higher risk of heart and kidney disease, stroke and death. This study is designed to reduce the barriers that prevent patients from taking their high blood pressure medications.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Computer
- BEHAVIORAL Reduction in financial barrier
- BEHAVIORAL Computer intervention & reduction of financial barrier
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 802 participants |
| Start Date | 2005-03 |
| Est. Completion | 2008-08 |
| Phase | Phase 4 |
What the finished NCT00133068 record still lists
NCT00133068 is an interventional study that assigns participants to a tested intervention. The registered 802 participants enrollment target is mid-sized for trials with a published cap, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (55% higher).
The record links to 0 conditions, and to 4 interventions - of which Control is the first listed.
NCT00133068 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00133068 about?
NCT00133068 is a clinical study titled "Collaboration to Reduce Disparities in Hypertension". A large number of African-American and low socioeconomic patients have poorly controlled high blood pressure because of not being able to take their high blood pressure medications. This puts these patients at higher risk of heart and kidney disease, stroke and death. This study is designed to reduc...
What is the current status of trial NCT00133068?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 802 participants. The study started on 2005-03. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00133068?
The interventions under investigation include: Control (BEHAVIORAL), Computer (BEHAVIORAL), Reduction in financial barrier (BEHAVIORAL), Computer intervention & reduction of financial barrier (BEHAVIORAL).
Who is sponsoring clinical trial NCT00133068?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00133068's enrollment target sits among peer trials
802 97th of 2000 higher than 1,903 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03524430 · 801 participants · NA
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy
- NCT04423211 · 804 participants · Phase 3
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- NCT06522022 · 804 participants · NA
PTSD Screening in Pregnant Black Women
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia